Promedior Alternatives & Competitors
12 companies similar to Promedior — Pioneering advanced therapies to heal fibrotic and inflammatory diseases at thei...
Companies similar to Promedior
Certa Therapeutics
Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...
Dianthus Therapeutics, Inc.
Building a leading biotech company focused in severe autoimmune diseases.
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
Flame Biosciences
A clinical-stage pioneer focused on discovering, developing, and commercializing groundbre...
Rival Readout
Competing with Promedior? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Angion
Angion is committed to transforming the treatment paradigm for patients suffering from fib...
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Molecure
Fate can be altered.
Solu Therapeutics
Solu Therapeutics is a next-generation therapeutics focused company working to eliminate c...
Inversago Pharma
Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrot...
Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoi...
Avalo Therapeutics
Innovation driven by compassion.
Enlivex Therapeutics (Nasdaq: ENLV)
Immune rebalancing
About Promedior
Promedior is a biopharmaceutical startup founded in 2006, focused on developing innovative treatments for inflammatory and fibrotic diseases. The company's unique drug discovery platform targets monocyte-derived cell populations critical in fibrotic, inflammatory, and autoimmune conditions, directly addressing the root...
Biopharmaceutical, Drug Discovery, Therapeutics, Fibrotic Diseases, Inflammatory Diseases, Clinical-stage, Monocyte-derived Cell Populations, Immunotherapy, Tissue Healing, Precision Medicine, Autoimmune Conditions, Eye Diseases, Lung Diseases, Kidney Diseases, Novel Therapeutics
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Promedior: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Promedior on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.